轻打 发表于 2025-3-30 12:10:39
MRA of the Peripheral Vasculatureements and is now widely applied in clinical practice throughout the world. The most widely used technique is to obtain a luminogram during first arterial passage of an extracellular MR contrast agent, often in combination with background subtraction to improve vessel-to-background contrast.chiropractor 发表于 2025-3-30 15:01:12
http://reply.papertrans.cn/23/2279/227828/227828_52.png镀金 发表于 2025-3-30 19:31:55
Whole-body MRAon of the systemic disease atherosclerosis is peripheral vascular occlusive disease (PAOD), while the most threatening manifestations are carotid, renal, and coronary artery stenoses [.–.]. All of these manifestations have in common that they need adequate imaging for early detection and optimized tLUCY 发表于 2025-3-30 21:53:39
Endoleak Imaging vascular surgeons were increasingly confronted with older patients with severe co-morbidity, attempts for less invasive aneurysm treatment were made. In 1991, Parodi et al. [.] were the first to report successful endovascular aortic aneurysm repair (EVAR) in human patients. Their technique involved起皱纹 发表于 2025-3-31 02:11:57
Gastrointestinal Bleeding practice to subdivide GI bleeding disorders into upper und lower GI bleeding. Upper GI bleeding (UGIB) denotes bleeding sources in the esophagus and stomach, sometimes including the duodenum up to the ligament of Treitz. Conversely, lower GI bleeding (LGIB) encompasses bleeding pathologies that ari集聚成团 发表于 2025-3-31 06:06:07
Vasovist® for Imaging Ischemic and Congenital Heart Disease years, the evidence on many indications in the diagnosis of CAD and heart failure with CMR has accumulated [., .]. CMR provides combined diagnostic information, such as visualization of the vascular tree, cardiac anatomy and function, as well as measurements of blood flow in the vessels, ventriculaALE 发表于 2025-3-31 09:37:15
Vasovist® in Brain Tumor Imagingrast medium with a pronounced and reversible protein binding, resulting in a long blood half-life. The agent is categorized as an intravascular or blood pool agent and was developed for MR angiographic applications, allowing imaging in a submillimeter resolution range in the equilibrium phase.liaison 发表于 2025-3-31 16:56:21
Book 20081st editionhniques, safety, efficacy, image processing, and pharmacoeconomic details, to successfully implement a new level of MRA image quality with this new contrast agent. In addition to improving all the usual arterial phase MRA - plications, the blood pool distribution opens up new possibilities, includin